Clozapine is associated with secondary antibody deficiency

BACKGROUND: Schizophrenia affects 1% of the population. Clozapine is the only medication licensed for treatment-resistant schizophrenia and is intensively monitored to prevent harm from neutropenia. Clozapine is also associated with increased risk of pneumonia although the mechanism is poorly unders...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Br J Psychiatry
Κύριοι συγγραφείς: Ponsford, Mark, Castle, Daniel, Tahir, Tayyeb, Robinson, Rebecca, Wade, Wendy, Steven, Rachael, Bramhall, Kathryn, Moody, Mo, Carne, Emily, Ford, Catherine, Farewell, Daniel, Williams, Paul, El-Shanawany, Tariq, Jolles, Stephen
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: Cambridge University Press 2019
Θέματα:
Papers
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6429246/
https://ncbi.nlm.nih.gov/pubmed/30259827
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1192/bjp.2018.152
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια